These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8005231)

  • 21. The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.
    Jaksić B; Vitale B; Hauptmann E; Planinc-Peraica A; Ostojic S; Kusec R
    Br J Cancer; 1991 Aug; 64(2):345-8. PubMed ID: 1892761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia (CLL) in younger adults: a retrospective study of 133 cases.
    De Rossi G; Mandelli F; Covelli A; Luciani M; Martelli M; Resegotti L; Alberti A; Cajozzo A; Deriu L; De Biasi R
    Hematol Oncol; 1989; 7(2):127-37. PubMed ID: 2921008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic lymphatic leukemia. I. Clinico-biological features and survival analysis. Study of 187 patients].
    Jarque I; Sanz G; Gomis F; Martínez G; de la Rubia J; López F; Sanz MA
    Sangre (Barc); 1991 Aug; 36(4):277-84. PubMed ID: 1776106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of young CLL patients: a single-centre experience from Turkey.
    Pamuk GE; Pamuk ON; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Haematologia (Budap); 2002; 31(4):303-11. PubMed ID: 12038513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.
    Matuszak M; Lewandowski K; Czyż A; Kiernicka-Parulska J; Przybyłowicz-Chalecka A; Jarmuż-Szymczak M; Lewandowska M; Komarnicki M
    Leuk Res; 2016 Aug; 47():166-71. PubMed ID: 27376546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lymphocytic leukemia: a retrospective study of 122 cases.
    Erlanson M; Osterman B; Jonsson H; Lenner P
    Eur J Haematol; 1994 Feb; 52(2):108-14. PubMed ID: 8119380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleolus organizer regions (AgNORs) and total tumor mass are independent prognostic parameters for treatment-free period in chronic lymphocytic leukemia.
    Metze K; Lobo AM; Lorand-Metze I
    Int J Cancer; 2000 Sep; 89(5):440-3. PubMed ID: 11008206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
    Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
    Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukaemia.
    Br J Haematol; 1990 Sep; 76(1):45-57. PubMed ID: 2223648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.
    Michallet M; Archimbaud E; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Rozman C; Gratwohl A; Gale RP
    Ann Intern Med; 1996 Feb; 124(3):311-5. PubMed ID: 8554226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome.
    Callea V; Morabito F; Oliva BM; Stelitano C; Levato D; Dattilo A; Gangemi F; Iorfida A; Iacopino P; Nobile F; Molica S; Brugiatelli M
    Br J Haematol; 1999 Nov; 107(2):347-52. PubMed ID: 10583223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
    Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
    Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
    Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
    Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients.
    Baumann T; Moia R; Gaidano G; Delgado J; Condoluci A; Villamor N; Payedimarri AB; Costa D; Patriarca A; Jiménez-Vicente C; Rossi D; Montserrat E
    Leukemia; 2021 Aug; 35(8):2325-2331. PubMed ID: 33542480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
    Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
    Leuk Res; 2000 Jun; 24(6):469-74. PubMed ID: 10781679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.